Clinical Trials in Parkinson’s diseases


To develop a promising drug or treatment for Parkinson’s disease observational study is being conducted by scientist in laboratory to provide patients with better life. Clinical trials are performed to slowdown the progression and reduce the symptoms.



 


  • Neuronal plasticity
  • Electrical Impulse
  • Cognitive Stimulation Therapy (CST)

Related Conference of Clinical Trials in Parkinson’s diseases

December 04-05, 2023

5th International Conference on Neurologists

Prague, Czech Republic
December 11-12, 2023

5th World Brain Congress

Rome, Italy
February 01-02, 2024

33rd world congress on Neurology and Therapeutics

Dubai, UAE
February 08-09, 2024

4th Annual Dementia Congress

Paris, France
February 08-09, 2024

5th Global Summit on Brain Disorders and Therapeutics

Madrid, Spain
February 08-09, 2024

6th World Depression Congress

Paris, France
March 14-15, 2024

36th World Conference on Neurology

Paris, France
March 18-19, 2024

28th International Conference on Neurology & Neurophysiology

Zurich, Switzerland
April 11-12, 2024

36th World Congress on Neurorehabilitation

Amsterdam, Netherlands
April 11-12, 2024

38th European Neurology Congress

Amsterdam, Netherlands
April 11-12, 2024

36th World Neuroscience and Neurology Conferences

Amsterdam, Netherlands
May 30-31, 2024

2nd International conference on Neuro Surgery

Vienna, Austria
June 13-14, 2024

37th European Neurology Congress 2024

Rome, Italy
June 27-28, 2024

2nd International conference on Dementia

London, UK
August 13-14, 2024

14th Global Alzheimers Summit

Amsterdam, Netherlands

Clinical Trials in Parkinson’s diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in